Omniscient Secures New CPT® Code for Connectomic Analysis, Validating the Clinical Utility of Brain Network Mapping ...
Omniscient (“o8t®”), a global pioneer in the use of AI to decode the human brain, today announced the issuance of a new Category ...
The new CPT code reflects the latest efficacious medical care available to patients, facilitating adoption and utilization.The assignment of a ...
Inspire Medical Systems has appointed Matt Osberg as Executive Vice President and Chief Financial Officer, effective January 19, 2026, while also issuing preliminary fourth-quarter and full-year 2025 ...
AngioDynamics shows how product mix shifts toward higher-margin Med Tech platforms are quietly reshaping earnings power ...
The Business Corner is a bimonthly column by Shakeel Ahmed, MD, CEO of St. Louis-based Atlas Surgical Group. This is the second installment. Over the last few months, I have noticed a subtle but ...
A newly released, data-driven reimbursement analysis from ModuleMD, based on 10+ million Allergy & Immunology claims from 2021–2025, reveals a clear message: the economics of allergy care are changing ...
ANGO, BSX and MDT are showing earnings quality improve as higher-margin products take share, supporting margins and durable ...
Elucid today announced that, effective January 1, 2026, its Plaque-IQ(TM) coronary plaque analysis has received a new Category I Current Procedural Terminology (CPT(R)) designation, alongside ...
SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and ...
Fourth quarter revenue expected to be $15.9 million to $16.1 million, representing growth of 4% to 5%Full year revenue expected to be $56.5 million to $56.7 million, representing growth of 10% to 11%F ...
The latest announcement is out from CVRx ( (CVRX) ).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results